PANCREAS Flashcards
Absolute C/I endoscopic drainage of panc pseudocyst
pseudocyst c/b pseudoaneurysm
Ranson’s criteria components (on admission) - severity
WBC >16 Age >55 glucose >200 AST >250 LDH >250
Ranson’s criteria components (48hrs into admission) - severity
Hct drop >10% BUN increase >5 Ca<8 within 48hrs PaO2 <60mmHg Base deficit (24-bicarb) >4 Fluid needs >6L within 48hrs
Size cut-off in which pseudocysts unlikely to resolve spontaneously
> 6cm
STEP-UP approach for mgmt necrotic pancreatitis
better prognosis if prolong surgical intervention
- ICU support, NPO, IVF, TPN/distal feeding tube
- if failing or sign of infection -> IV Abx, possible perQ drain
- Re-scan after perQ and still have fluid -> upsize drain, re-placement
- If worsening still -> video-assisted RP debridement (via flank)
Ranson criteria score that predicts 100% mortality
8
Atlanta classification system
- necrotizing vs. interstitial edematous
2. fluid vs. no fluid collection (and for how long?)
Puestow procedure; indications?
longitudinal pancreaticojejunostomy (decompressive operation); for large-duct chronic pancreatitis (>6mm) + normal panc head
Beger procedure
duodenal-preserving panc head resection
Frey procedure; indications?
lateral longitudinal pancreaticojejunostomy w/ excavation of panc head wo transection of pancreas (decompressive + resection of disease); for primary panc head involvement w/ or w/o duct dilation
Mgmt minimal change pancreatitis
- total pancreatectomy
- if high surgical risk, then denervation via bilateral thoracoscopic splanctenectomy
Dx cystic pancreatic neoplasms
- most found incidentally
- further characterization w/ MRCP
- EUS + FNA will differentiate type
FNA of cystic pancreatic neoplasms
- high CEA (>190) -> mucinous
- high amylase -> ductal communication (ie. pseudocyst, IPMN)
Demographics of cystic pancreatic neoplasms
F>M
- younger -> think solitary pseudopapillary lesions
- middle-aged -> think mucinous
- elderly -> think serous
Imaging characteristic: serous cystadenoma
well-circumscribed; multicystic, lobulated mass (“bunch of grapes”) +/- central stellate scar
Imaging characteristics: mucinous cystadenoma
thick-walled, single cyst with internal septations +/- peripheral calcifications
Pathognomonic endoscopic finding for main duct IPMN
fish-mouth papilla
Worrisome EUS findings for branch duct IPMN
- cyst >3cm (for young pts, <2cm)
- thickened cyst wall
- non-enhancing mural nodules
- lymphadenopathy
- main duct >10mm
- abrupt change in main duct size w/ distal atrophy
MC PNET
nonfunctional
MC functional PNET
insulinoma
MC PNET associated with MEN1
gastrinoma
Nonfunctional PNET (malignancy? location? sxs?)
- majority malignant
- MC head of panc
- dx late bc incidentally found or mass effect
Insulinoma (malignancy? location? sxs?)
- most benign
- evenly distributed throughout panc
- Whipple’s triad
Whipple’s triad
- fasting hypoglycemia
- neuroglycopenic sxs
- relief sxs w/ glucose
Labs: Insulinoma
- plasma glucose <55
- insulin >18
- C-peptide > 0.6
- pro-insulin >5
- beta-hydroxybuterate <2.7
- increase plasma glucose >25 after glucose admin
- neg urine test for oral hypoglycemic
Mgmt insulinoma
depends on location, suspicion for malignancy + presence of other tumors
- solitary benign -> enucleation
- distal -> distal spleen preserving pancreatectomy
- malignant -> formal resection
Gastrinoma (malignancy? location? sxs?)
- most malignant
- located gastrinoma triangle
- abd pain + diarrhea + weight loss + peptic ulcer disease
Gastrinoma triangle
- jxn CBD + CD
- jxn neck/body panc
- jxn 2nd/3rd duodenum
If cannot localize gastrinoma, go to OR and do…
- intra-op US
- transduodenal palpation
- intra-op upper endoscopy w/ transduo illumination
- duodenotomy, then palpate head of panc
Mgmt gastrinoma
- if small in duodenal mucosa -> enucleation + paraduo LN dissection
- if noninvasive, <5cm at head -> (same as above)
- if invasive or >5cm, at head -> Whipple
- if in body/tail -> distal panc
Glucagonoma (malignancy? location? sxs?)
- most malignant
- MC tail of panc
- sxs: dermatitis, DM, depression, DVT + necrolytic migratory erythema
Mgmt glucagnoma
NO enucleation, need resection w/ regional lymphadenectomy (bc high malignant potential) + cholecystectomy (bc need somatostatin adjuvant)
Somatostatinoma (malignancy? location? sxs?)
- most malignant
- MC head of panc, can be at 2nd duo
- sxs: cholecystitis, DM, malabsorption, steatorrhea
Mgmt somatostatinoma
NO enucleation, need resection w/ regional lymphadenectomy + cholecystectomy
VIPoma (malignancy? location? sxs?)
- most malignant
- MC body/tail panc (extrapanc also possible @ adrenal, RP, mediastinum)
- sxs: WDHA
Mgmt VIPoma
NO enucleation, need resection w/ regional lymphadenectomy + cholecystectomy (bc somatostatin adjuvant)
Characteristics of resectable panc adenocarcinoma
- no arterial contact
- <180 degree contact SMV or portal vein
- wo vein contour irregularity (which would indicate invasion into vasculature structure)
Characteristics of unresectable panc adenocarcinoma
- distant mets
- > 180 degree contact w/ SMA or celiac
- unresectable involvement with SMV or portal vein
What is / who gets adjuvant for panc adenocarcinoma?
everyone; folinic acid (leucovorin) + 5FU + irinotecan + oxaliplatin
hx pancreatitis + hematemesis, think…?
gastric varices 2/2 splenic vein thrombosis
2-cm branch IPMN incidental + microcytic anemia, also need w/u for…?
colonoscopy; bc IPMN pts have higher incidence extra-panc malignancy (MC colonic adenocarcinoma)
Mutations associated w/ panc adenocarcinoma
- KRAS
- p53
- CDKN2A
- SMAD4
Mgmt pancreatic fistula
- most will close spontaneously 4-6 wks
- ERCP w/ stent if still signif output (will close 85% pts)
- somatostatin analog NOT helpful and is expensive